Inside the GLP-1 Boom: What a Biotech Analyst and PhD/Nutritionist Thinks Mini-deep dive on the fastest growing healthcare opportunity from an investment and health perspective This is for: Science enthusiasts Pharma/biotech consultants, analysts Investors in the life science space Doctors, nutritionists, health coaches, fitness coaches People considering or already on weight loss medication Longevity enthusiasts I help you: Understand what weight loss medications are Get a list of the key obesity players in the pharma/biotech space Understand lifestyle strategies to get the best outcomes out of GLP1s Free Resources included: Obesity development landscape and launch timelines Weight loss data from key drugs in development Comment Health and I will share a US market model template to help you forecast weight loss drug sales yourself See inside for disclosure Intro to Weight Loss Medications (WLMs) Unless you are living under a rock, the words GLP1, Ozempic, Wegovy, Mounjaro, weight-loss medication must not be new to you

For a comprehensive list of errors that extends beyond reconstitution to all aspects of peptide handling, the common peptide mistakes beginners make article covers over a dozen pitfalls that catch even experienced researchers off guard
The BPC-157 vs TB-500 comparison helps understand when each might be preferable
It is one more reason the effects of a ghrelin mimetic like GHRP-2 are best understood as modulating an existing rhythm rather than imposing a new one
Step 1: Focus on hydration